首页> 外文期刊>Frontiers in Bioengineering and Biotechnology >Reconstruction of Large Skeletal Defects: Current Clinical Therapeutic Strategies and Future Directions Using 3D Printing
【24h】

Reconstruction of Large Skeletal Defects: Current Clinical Therapeutic Strategies and Future Directions Using 3D Printing

机译:大骨骼缺陷的重建:当前使用3D打印的临床治疗策略和未来方向

获取原文
           

摘要

The healing of bone fractures is a well-orchestrated physiological process involving multiple cell types and signaling molecules interacting at the fracture site to replace and repair bone tissue without scar formation. However, when the lesion is too large, normal healing is compromised. These so-called non-union bone fractures, mostly arising due to trauma, tumor resection or disease, represent a major therapeutic challenge for orthopedic and reconstructive surgeons. In this review, we firstly present the current commonly employed surgical strategies comprising auto-, allo- and xenograft transplantations, as well as synthetic biomaterials. Further to this, we discuss the multiple factors influencing the effectiveness of the reconstructive therapy. One essential parameter is adequate vascularization that ensures the vitality of the bone grafts and thereby supports the regeneration process, with deficient vascularization presenting as a serious problem frequently encountered in current management strategies. To address this challenge, vascularized bone grafts, including free or pedicled fibula flaps, or in situ approaches using the Masquelet induced membrane, or the patient`s body as a bioreactor, comprise feasible alternatives. Finally, we highlight future challenges and novel strategies such as 3D printing and bioprinting which could overcome some of the current challenges in the field of bone defect reconstruction, with the benefit of fabricating personalized and vascularized scaffolds.
机译:骨折的愈合是稳定的生理过程,涉及多种细胞类型和信号分子在骨折部位相互作用,以替代和修复没有疤痕的骨组织。但是,当病变过大时,妥协愈合普通愈合。这些所谓的非联合骨折骨折,主要是由于创伤,肿瘤切除或疾病导致的,代表了整形外科和重建外科医生的主要治疗挑战。在本综述中,我们首先介绍了当前常用的外科策略,包括自动,丙醇和异种移植移植以及合成生物材料。此外,我们讨论了影响重建疗法有效性的多种因素。一种基本参数是足够的血管化,可确保骨移植物的活力,从而支持再生过程,缺乏血管化作为当前管理策略经常遇到的严重问题。为了解决这一挑战,包括使用Masquelet诱导膜或患者身体作为生物反应器的血管化骨移植物,包括自由或束腓骨襟翼,或原位方法包括可行的替代品。最后,我们突出了3D印刷和生物制品等未来的挑战和新颖的策略,这可能克服了骨缺陷重建领域的一些当前挑战,具有制造个性化和血管化的脚手架的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号